Real-time enrollment status for this pulmonary arterial hypertension clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT05587712 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Arterial Hypertension |
| Phase | Clinical Trial |
| Target Enrollment | 42 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | January 21, 2026 (Jan 21, 2026) |
As of March 2, 2026: Clinical trial NCT05587712 is currently recruiting participants. This clinical trial study for pulmonary arterial hypertension is actively seeking new participants at 10 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05587712 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05587712 was last updated Jan 21, 2026 (January 21, 2026). HelloStudys verifies this status automatically.